Repligen | أرباح التشغيل



Operating Profit تغيير تاريخ
Agilent USD 300M 76M 2025-04
Align Technology USD 131.1M 13.05M 2025-03
Bio Techne USD 38.71M 8.71M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Bruker USD 31.8M 32.3M 2025-03
Charles River Laboratories USD 74.67M 242.36M 2025-03
Danaher USD 760M 523M 2025-06
Dentsply International USD 63M 572M 2025-03
Exact Sciences USD -96010000 780.34M 2025-03
General Electric Aerospace USD 2.1B 356M 2025-06
Henry Schein USD 175M 20M 2025-03
Illumina USD 131M 44M 2025-03
IQVIA Holdings USD 556M 64M 2025-06
Mettler Toledo International USD 201.94M 112.6M 2025-03
Myriad Genetics USD -29000000 10M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Repligen USD 6.58M 43.08M 2025-03
Revvity USD 72.23M 46.52M 2025-03
Standard Biotools USD -32817000 1.1M 2024-12
Thermo Fisher Scientific USD 1.92B 200M 2025-06
Waters USD 151.74M 140.52M 2025-03
West Pharmaceutical Services USD 153.7M 46.7M 2025-06


Repligen أرباح التشغيل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.